These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 15151617)
1. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617 [TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1). Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696 [TBL] [Abstract][Full Text] [Related]
5. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. Fong LY; Zhang L; Jiang Y; Farber JL J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379 [TBL] [Abstract][Full Text] [Related]
6. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664 [TBL] [Abstract][Full Text] [Related]
10. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Ding XZ; Tong WG; Adrian TE Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335 [TBL] [Abstract][Full Text] [Related]
11. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888 [TBL] [Abstract][Full Text] [Related]
12. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells. Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308 [TBL] [Abstract][Full Text] [Related]
15. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
16. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
18. Significance of COX-2 expression in human esophageal squamous cell carcinoma. Zhi H; Wang L; Zhang J; Zhou C; Ding F; Luo A; Wu M; Zhan Q; Liu Z Carcinogenesis; 2006 Jun; 27(6):1214-21. PubMed ID: 16352617 [TBL] [Abstract][Full Text] [Related]
19. [Expression of cyclooxygenase-2 in esophageal squamous cell carcinogenesis]. Yu HP; Liu L; Shi LY; Lu WH; Xu SQ Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):22-5. PubMed ID: 14989896 [TBL] [Abstract][Full Text] [Related]
20. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]